Bio

Edward Bromley is a member of Reed Smith's Global Corporate Group and its Life Sciences Health Industry Group. His practice focuses on mergers and acquisitions, securities, corporate governance, general corporate and financing matters. He is experienced in counseling a wide range of clients, from early-stage companies to well-established, publicly traded companies. He has worked closely with the Boards of Directors of clients, their senior management and other personnel in pharmaceutical, biotechnology, medical device and other life sciences companies, as well as companies in the consumer products, information technology, software, telecommunications, and energy and natural resources industries. Tad represents issuers and stockholders in public offerings of securities, including secondary offerings and the resale of securities. He also advises public companies on SEC periodic reporting and proxy requirements, including compensation disclosure and related compliance matters. He represents issuers, venture groups and investors in various forms of private financings, including private placements, debt and equity bridge financings, and venture capital financings. Tad has substantial experience in structuring, negotiating and documenting various complex business transactions, including mergers and acquisitions, recapitalizations and reorganizations, exchange offers, licensing and technology transfer arrangements, and joint venture formations. Tad also has 25 years of experience representing companies in the negotiation and preparation of a broad range of operational agreements, commercial arrangements and governance matters, such as consulting, licensing, shareholder, operating, partnership, confidentiality and employment agreements. He also advices Boards , Audit Committees and Compensation Committees.